[HTML][HTML] Inhaled antifungal agents for treatment and prophylaxis of bronchopulmonary invasive mold infections

K Brunet, JP Martellosio, F Tewes, S Marchand… - Pharmaceutics, 2022 - mdpi.com
Pulmonary mold infections are life-threatening diseases with high morbi-mortalities.
Treatment is based on systemic antifungal agents belonging to the families of polyenes …

[HTML][HTML] Conventional antifungals for invasive infections delivered by unconventional methods; aerosols, irrigants, directed injections and impregnated cement

RH Drew, JR Perfect - Journal of Fungi, 2022 - mdpi.com
The administration of approved antifungals via unapproved formulations or administration
routes (such as aerosol, direct injection, irrigation, topical formulation and antifungal …

[HTML][HTML] Airway necrosis and granulation tissue formation caused by Rhizopus oryzae leading to severe upper airway obstruction: a case report

GJ Chen, XB Chen, WY Rao, XY Pan, SY Li… - Frontiers in Cellular …, 2024 - frontiersin.org
Pulmonary Mucormycosis is a fatal infectious disease with high mortality rate. The
occurrence of Mucormycosis is commonly related to the fungal virulence and the host's …

[HTML][HTML] Efficacy of different durations of antifungal prophylaxis with nebulized amphotericin B after lung transplantation: a retrospective cohort study

C Ju, Q Lian, X Wang, L Wang, J Zhang… - Journal of Thoracic …, 2023 - ncbi.nlm.nih.gov
Background Nebulized amphotericin B (NAB) is recommended for preventing invasive
fungal diseases (IFDs) after lung transplantation. However, the optimal duration of NAB …

[HTML][HTML] Future directions for clinical respiratory fungal research

D Armstrong-James - Mycopathologia, 2021 - Springer
There has been a growing appreciation of the importance of respiratory fungal diseases in
recent years, with better understanding of their prevalence as well as their global …